Home / RHINE RENOVIA
RHINE RENOVIA

RHINE RENOVIA

RHINE RENOVIA

ADVANCING UROLOGY WITH PRECISION AND CARE.

A division dedicated to redefining excellence in urology care. Rhine Renovia stands strong with a mission to provide innovative and trusted healthcare solutions in the field of urology. Backed by a committed team and a progressive vision, the division focuses on delivering quality products that support better patient outcomes and medical advancements. With its growing presence and consistent performance, Rhine Renovia continues to build confidence among healthcare professionals while setting new benchmarks in specialized care.

OUR PRODUCTS

Experience the ultimate combination of quality and efficacy with our premium products, designed to exceed your expectations and enhance your everyday life.
  • TAMSHRINE 0.4 mg

    TAMSHRINE 0.4 mg

    Sold out

    TAMSHRINE 0.4 mg

    TAMSHRINE 0.4 mg

    TAMSHRINE 0.4 mg

    Ingredients

    Each Film Coated Tablet Contains: Tamsulosin HCL IP 0.4 mg (in a Extended Release Form) Excipient q.s. Colour: Titanium Dioxide IP

    Description

    Tamsulosin selectively antagonizes α1A-adrenergic receptors located predominantly in the smooth muscle of the prostate, prostatic urethra, and bladder neck. This results in smooth muscle relaxation, reducing bladder outlet resistance and improving urinary flow.

    Sold out
  • URIRHINE MB6

    URIRHINE MB6

    Sold out

    URIRHINE MB6

    URIRHINE MB6

    URIRHINE MB6

    Ingredients

    Each 5 ml. contains: Pottassium Citrate Monohydrate IP 1100mg, Magnesium Citrate USP 375 mg, Pyridoxine Hydirchloride IP 20 mg In a flavoured syrupy base q.s.

    Description

    Potassium Citrate + Magnesium Citrate + Vitamin B6 (Pyridoxine) is a commonly used combination medicine for kidney stone prevention and urinary health.

    Main Uses

    * Helps prevent kidney stone formation
    * Reduces recurrence of calcium oxalate stones
    * Makes urine less acidic (alkalinizes urine)
    * Helps reduce burning urination in some urinary conditions

    Sold out
  • SILORHINE-D8

    SILORHINE-D8

    Sold out

    SILORHINE-D8

    SILORHINE-D8

    SILORHINE-D8

    Ingredients

    Each hard gelatin capsule contains: Silodosin JP 8 mg, Dutasteride IP 0.5mg Excipients q.s

    Description

    LUTS associated with
    BPH & Enlarged Prostate
    SILORHINE-D8
    Silodosin 8mg + Dutasteride 0.5mg Capsules
    88.8% TWO success rate at 12 weeks.
    Demonstrated significant improvements in Qmax, IPSS & IPSS-QoL score consistently throughout the12 weeks study period.
    Extended combination therapy delays AUR
    onset and lowers surgical need.

    Sold out
  • TAMSRHINE-D

    TAMSRHINE-D

    Sold out

    TAMSRHINE-D

    TAMSRHINE-D

    TAMSRHINE-D

    Ingredients

    Each Film Coated Prolonged Release Tablet Contains: Dutasteride Ip 0.5 mg  Tamsulosin HCI IP 0.4 mg (In an Extended Release Form) Excipients q.s

    Description

    For effective management of BPH
    Tamsulosin 0.4mg + Dutasteride 0.5mg Tablets
    Dual-action synergy for optimal BPH control
    Reduces prostatic DHT levels
    Lowers the need for BPH-related surgeries
    • Tamsulosin relaxes prostate and bladder muscles,Dutasteride: 5a-reductase inhibitor
    • Single daily dose improves compliance

    Sold out
  • MIRARHINE - 50

    MIRARHINE - 50

    Sold out

    MIRARHINE - 50

    MIRARHINE - 50

    MIRARHINE - 50

    Ingredients

    Each Film Coated Prolonged Release Tablet Contains: Mirabegron 50 mg Excipients q.s

    Description

    In the management of OAB
    Mirabegron 50mg Tablets
    • Proven efficacy and excellent tolerability in patients ≥75 years.
    * Superior 12 months treatment persistence and adherence compared to anti-muscaranics.
    Lower dementia risk compared to anti-cholinergics.
    • AUA/SUFA: dementia risk increase after 3+ months of anti-cholinergics.
    Patients with inadequate response to current regimens
    Newly diagnosed patients focused on QoL
    Elderly patients with unique treatment needs
    Mirabegron 50mg Tablets

    Sold out
  • MIRARHINE - 25

    MIRARHINE - 25

    Sold out

    MIRARHINE - 25

    MIRARHINE - 25

    MIRARHINE - 25

    Ingredients

    Each Film Coated Prolonged Release Tablet Contains: Mirabegron 25 mg Excipients q.s

    Description

    In the management of OAB
    Mirabegron 25mg Tablets
    • Proven efficacy and excellent tolerability in patients ≥75 years.
    * Superior 12 months treatment persistence and adherence compared to anti-muscaranics.
    •
    Lower dementia risk compared to anti-cholinergics.
    • AUA/SUFA: dementia risk increase after 3+ months of anti-cholinergics.
    Patients with inadequate response to current regimens
    Newly diagnosed patients focused on QoL
    Elderly patients with unique treatment needs
    Mirabegron 25mg Tablets

    Sold out
  • ALFARHINE

    ALFARHINE

    Sold out

    ALFARHINE

    ALFARHINE

    ALFARHINE

    Ingredients

    Each Film Coated Prolonged Release Tablet Contains: Alfuzosin Hydrochloride IP 10 mg Excipients q.s.

    Description

    Alfuzosin 10 mg is a prescription medicine mainly used to treat symptoms of benign prostatic hyperplasia (BPH)—an enlarged prostate in men.
    Alfuzosin works by relaxing the muscles in the prostate and bladder neck, which helps:

    * Improve urine flow
    * Reduce difficulty starting urination
    * Decrease frequent or urgent urination
    * 10 mg once daily, usually taken after the same meal each day.
    * Swallow the tablet whole (don’t crush or chewe

    Sold out
  • SILORHINE 8

    SILORHINE 8

    Sold out

    SILORHINE 8

    SILORHINE 8

    SILORHINE 8

    Ingredients

    Each hard gelatin capsule contains: Silodosin 8mg Excipients q.s.

    Description

    TO TREAT THE SYMPTOMS OF AN ENLARGED PROSTATE (BENIGN PROSTATIC HYPERPLASIA; BPH), WHICH INCLUDES DIFFICULTY IN URINATING (HESITATION, DRIBBLING, WEAK STREAM AND INCOMPLETE BLADDER EMPTYING), PAINFUL URINATION AND URINARY FREQUENCY AND URGENCY.

    Sold out